Zoledronic Acid Monohydrate

6 trials 3 recruiting MMusculoskeletal

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

3 Completed trials

7 Sponsors

5 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 2 Phase IV: 2

Indications tested

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 1 Institut De Cancerologie De L Ouest 1 NHS Lothian 1 Pauls Stradins Clinical University Hospital 1 Region Midtjylland 1 Unicancer 1 University Of Edinburgh 1

All trials

6 total

A prospective randomized open-label phase II clinical study evaluating the efficacy and safety of zoledronic acid addition to standard thera… Recruiting

2024-519446-67-00 Phase II 1 country Pauls Stradins Clinical University Hospital
Strategies for zoledronic acid post-denosumab discontinuation in postmenopausal osteoporosis Recruiting

2024-511871-13-00 Phase IV 1 country Centre Hospitalier Universitaire De Toulouse
Multicentre, randomized, controlled, open-label, multi-centre medicoeconomic study evaluating the efficacy of adding zoledronic acid or deno… Recruiting

2024-513248-27-00 Phase III 1 country Institut De Cancerologie De L Ouest
RGX Ended

2024-514903-33-00 Phase II 1 country Region Midtjylland
Treatment protocol for osteosarcomas in children, adolescents and adults including a randomized trial and biological studies Ended

2024-514756-32-00 Phase III 1 country Unicancer
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid Ended

2024-519705-36-00 Phase IV 4 countries NHS Lothian; University Of Edinburgh

Showing 1–6 of 6 trials

← All drugs A–Z